Susquehanna International Group
ZSAN

Susquehanna International Group’s Zosano Pharma Corporation ZSAN Stock Holding History

Susquehanna International Group’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-115
Closed -$42K – 10493
2017
Q4 		$42K Buy
+115
New +$57.7K ﹤0.01% 8955
2017
Q3 		– Sell
-15
Closed -$15K – 9916
2017
Q2 		$15K Buy
+15
New +$15.5K ﹤0.01% 9057
2017
Q1 		– Sell
-766
Closed -$418K – 10334
2016
Q4 		$418K Buy
+766
New +$378K ﹤0.01% 7353

Other funds holding ZSAN

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Susquehanna International Group's ZSAN Position: Q1 2018 in Review

Susquehanna International Group sold out of Zosano Pharma Corporation (ZSAN) in Q1 2018, closing a stake of 115 shares — an estimated $42K sold.

Susquehanna International Group first reported a position in ZSAN in Q4 2016 and held it in 3 quarters. The position peaked at $418K in Q4 2016. 32 funds tracked by Wall St. Rank hold ZSAN as of Q1 2018.

  • Susquehanna International Group reported no remaining Zosano Pharma Corporation position as of Q1 2018 after selling out during the quarter.
  • Susquehanna International Group sold 115 Zosano Pharma Corporation shares in Q1 2018, an estimated $42K.
  • Susquehanna International Group first reported a position in Zosano Pharma Corporation in Q4 2016 and held it in 3 quarters.
  • Susquehanna International Group's Zosano Pharma Corporation position peaked at $418K in Q4 2016.
  • 32 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q1 2018.

Based on Susquehanna International Group's 13F filing for Q1 2018, filed 15 May 2018.